On Invalid Date, Qiagen Nv (NYSE: QGEN) reported Q4 2023 earnings per share (EPS) of $0.40, up 15.07% year over year. Total Qiagen Nv earnings for the quarter were $97.66 million. In the same quarter last year, Qiagen Nv's earnings per share (EPS) was $0.35.
As of Q2 2024, Qiagen Nv's earnings has grown -19.35% year over year. This is 8.38 percentage points lower than the US Diagnostics & Research industry earnings growth rate of -10.97%. Qiagen Nv's earnings in the past year totalled $341.30 million.
What is QGEN's earnings date?
Qiagen Nv's earnings date is Invalid Date. Add QGEN to your watchlist to be reminded of QGEN's next earnings announcement.
What was QGEN's revenue last quarter?
On Invalid Date, Qiagen Nv (NYSE: QGEN) reported Q4 2023 revenue of $509.16 million up 2.24% year over year. In the same quarter last year, Qiagen Nv's revenue was $497.98 million.
What was QGEN's revenue growth in the past year?
As of Q2 2024, Qiagen Nv's revenue has grown -8.23% year over year. This is 8.68 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 0.45%. Qiagen Nv's revenue in the past year totalled $1.97 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.